Alliancebernstein L.P. Rvl Pharmaceuticals PLC Transaction History

Alliancebernstein L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$2.8 - $3.78 $603,512 - $814,741	-215,540 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$4.12 - $6.29 $30,949 - $47,250	-7,512 Reduced 3.37%	215,540 $888,000
Q3 2020 Nov 12, 2020	SELL	$4.82 - $8.77 $141,409 - $257,294	-29,338 Reduced 11.62%	223,052 $1.21 Million
Q2 2020 Aug 13, 2020	BUY	$2.83 - $6.99 $40,469 - $99,957	14,300 Added 6.01%	252,390 $1.7 Million
Q1 2020 May 14, 2020	BUY	$3.18 - $7.0 $757,126 - $1.67 Million	238,090 New	238,090 $757,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.